These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12469003)

  • 1. Sequential changes in the plasma concentration of risperidone following intentional overdose.
    Nishikage H; Nakanishi T; Takamitsu Y; Yamamoto J
    Clin Neuropharmacol; 2002; 25(6):307-9. PubMed ID: 12469003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose.
    Titier K; Déridet E; Cardone E; Abouelfath A; Moore N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):373-8. PubMed ID: 12007783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia.
    Spina E; Avenoso A; Facciolà G; Salemi M; Scordo MG; Ancione M; Madia AG; Perucca E
    Psychopharmacology (Berl); 2001 Jan; 153(2):238-43. PubMed ID: 11205425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolism.
    Schoretsanitis G; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Schizophr Res; 2017 Jul; 185():51-57. PubMed ID: 27993531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
    Saito M; Yasui-Furukori N; Nakagami T; Furukori H; Kaneko S
    J Clin Psychopharmacol; 2005 Dec; 25(6):527-32. PubMed ID: 16282832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic patterns of risperidone-associated adverse drug reactions.
    Schoretsanitis G; Stegmann B; Hiemke C; Gründer G; Schruers KR; Walther S; Lammertz SE; Haen E; Paulzen M
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1091-8. PubMed ID: 27376639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overdose of risperidone.
    Springfield AC; Bodiford E
    J Anal Toxicol; 1996; 20(3):202-3. PubMed ID: 8735204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia.
    Nagasaki T; Ohkubo T; Sugawara K; Yasui N; Furukori H; Kaneko S
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):595-601. PubMed ID: 10704125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels.
    Lane HY; Chiu WC; Chou JC; Wu ST; Su MH; Chang WH
    J Clin Psychiatry; 2000 Mar; 61(3):209-14. PubMed ID: 10817107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
    Meltzer HY; Lindenmayer JP; Kwentus J; Share DB; Johnson R; Jayathilake K
    Schizophr Res; 2014 Apr; 154(1-3):14-22. PubMed ID: 24630262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations and side effects in psychiatric patients during risperidone therapy.
    Olesen OV; Licht RW; Thomsen E; Bruun T; Viftrup JE; Linnet K
    Ther Drug Monit; 1998 Aug; 20(4):380-4. PubMed ID: 9712460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis.
    Paulzen M; Haen E; Stegmann B; Hiemke C; Gründer G; Lammertz SE; Schoretsanitis G
    Psychoneuroendocrinology; 2016 Nov; 73():9-15. PubMed ID: 27448523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients.
    Suzuki Y; Fukui N; Tsuneyama N; Watanabe J; Ono S; Sugai T; Saito M; Inoue Y; Someya T
    Hum Psychopharmacol; 2012 Jan; 27(1):43-6. PubMed ID: 22745940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of paliperidone versus risperidone and clinical effects.
    Nazirizadeh Y; Vogel F; Bader W; Haen E; Pfuhlmann B; Gründer G; Paulzen M; Schwarz M; Zernig G; Hiemke C
    Eur J Clin Pharmacol; 2010 Aug; 66(8):797-803. PubMed ID: 20358189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response.
    Lostia AM; Mazzarini L; Pacchiarotti I; Lionetto L; De Rossi P; Sanna L; Sani G; Kotzalidis GD; Girardi P; Simmaco M; Tatarelli R
    Ther Drug Monit; 2009 Aug; 31(4):475-81. PubMed ID: 19531984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
    Kakihara S; Yoshimura R; Shinkai K; Matsumoto C; Goto M; Kaji K; Yamada Y; Ueda N; Ohmori O; Nakamura J
    Int Clin Psychopharmacol; 2005 Mar; 20(2):71-8. PubMed ID: 15729081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.
    Kang RH; Jung SM; Kim KA; Lee DK; Cho HK; Jung BJ; Kim YK; Kim SH; Han C; Lee MS; Park JY
    J Clin Psychopharmacol; 2009 Jun; 29(3):272-7. PubMed ID: 19440082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study.
    Uchida H; Mamo DC; Pollock BG; Suzuki T; Tsunoda K; Watanabe K; Mimura M; Bies RR
    Ther Drug Monit; 2012 Apr; 34(2):182-7. PubMed ID: 22377743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.